These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8471424)

  • 1. Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.
    De Giovanni C; Lollini PL; Dolcetti R; Landuzzi L; Nicoletti G; D'Andrea E; Scotland K; Nanni P
    Br J Cancer; 1993 Apr; 67(4):674-9. PubMed ID: 8471424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological, biochemical, and molecular biological characterization of a rat rhabdomyosarcoma cell line during differentiation induction in vitro.
    Gerharz CD; Doehmer J; Mayer H; Oesch F; Gabbert H
    Environ Health Perspect; 1990 Aug; 88():187-91. PubMed ID: 2272313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation induction in the human rhabdomyosarcoma cell line TE-671. A morphological, biochemical and molecular analysis.
    Ramp U; Gerharz CD; Engers R; Marx N; Gabbert HE
    Anticancer Res; 1995; 15(1):181-8. PubMed ID: 7733631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
    Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N,N-Dimethylformamide-induced morphological differentiation and reduction of tumorigenicity in cultured mouse rhabdomyosarcoma cells.
    Dexter DL
    Cancer Res; 1977 Sep; 37(9):3136-40. PubMed ID: 195720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of myogenic differentiation in human rhabdomyosarcoma cells by ionising radiation, N,N-dimethylformamide and their combination.
    Nicoletti G; De Giovanni C; Landuzzi L; Simone G; Rocchi P; Nanni P; Lollini PL
    Br J Cancer; 1992 Apr; 65(4):519-22. PubMed ID: 1562460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in proto-oncogene raf expression precedes differentiation induction in different clonal rhabdomyosarcoma subpopulations.
    Ramp U; Gerharz CD; Doehmer J; Oster O; Gabbert HE
    Anticancer Res; 1992; 12(2):537-46. PubMed ID: 1316093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uniform response of c-raf expression to differentiation induction and inhibition of proliferation in a rat rhabdomyosarcoma cell line.
    Ramp U; Gerharz CD; Doehmer J; Oster O; Gabbert HE
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(5):271-80. PubMed ID: 1980557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of the proto-oncogenes fos and raf in the rhabdomyosarcoma cell line BA-HAN-1C after differentiation induction with retinoic acid and N-methylformamide.
    Gabbert HE; Gerharz CD; Ramp U; Hoffmann J; Oster O; Oesch F; Doehmer J
    Int J Cancer; 1990 Apr; 45(4):724-30. PubMed ID: 2108933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells.
    Astolfi A; De Giovanni C; Landuzzi L; Nicoletti G; Ricci C; Croci S; Scopece L; Nanni P; Lollini PL
    Gene; 2001 Aug; 274(1-2):139-49. PubMed ID: 11675006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dexamethasone on induction of monocytic differentiation in human U-937 cells by dimethylsulfoxide.
    Nakamura T; Kharbanda S; Spriggs D; Kufe D
    J Cell Physiol; 1990 Feb; 142(2):261-7. PubMed ID: 2406276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoid hormones in human T lymphoblastic leukemic cells.
    Maroder M; Martinotti S; Vacca A; Screpanti I; Petrangeli E; Frati L; Gulino A
    Nucleic Acids Res; 1990 Mar; 18(5):1153-7. PubMed ID: 2320412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of memory, differentiation, and repression of c-myc and p53 genes in human RD/TE-671 cells induced by a ureido-derivative of pyridine (UDP-4).
    Pappas IS; Sophianos D; Tzartos S; Tsiftsoglou AS
    Cell Growth Differ; 1996 Jun; 7(6):797-809. PubMed ID: 8780893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid effect on oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM. Specific c-myc mRNA suppression by dexamethasone.
    Yuh YS; Thompson EB
    J Biol Chem; 1989 Jun; 264(18):10904-10. PubMed ID: 2659598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actinomycin D treatment leads to differentiation and inhibits proliferation in rhabdomyosarcoma cells.
    Marchal JA; Prados J; Melguizo C; Fernández JE; Vélez C; Alvarez L; Aránega A
    J Lab Clin Med; 1997 Jul; 130(1):42-50. PubMed ID: 9242365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid modulation of transformed cell proliferation is oncogene specific and correlates with effects on c-myc levels.
    O'Banion MK; Levenson RM; Brinckmann UG; Young DA
    Mol Endocrinol; 1992 Sep; 6(9):1371-80. PubMed ID: 1331773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of phorbol ester-induced monocytic differentiation by dexamethasone is associated with down-regulation of c-fos and c-jun (AP-1).
    Hass R; Brach M; Kharbanda S; Giese G; Traub P; Kufe D
    J Cell Physiol; 1991 Oct; 149(1):125-31. PubMed ID: 1939341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cAMP effects on myogenic gene expression in rhabdomyosarcoma cells.
    Wasserman LM; Newsham I; Huang HJ; Cavenee WK
    Exp Cell Res; 1996 Aug; 227(1):55-62. PubMed ID: 8806451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.